Back to Agenda
Poster Presentations and Networking Reception
Session Chair(s)
Session Chair Invited, BSN, DDS
Manager, DIA, Switzerland
Poster Presentations and Networking Reception
Speaker(s)
Michelle Hellstern, BSN
Manager, Clinical Trial Disclosure & Transparency, CSL Behring, United States
Redaction Impact and Efficiencies Assessed for Optimal Transparency Preparation for the EU Clinical Trial Regulation 536/2014
Raina Agarwal, MPHARM
Senior Manager, Kinapse Ltd, A Syneos Health Company, United States
Assessment of Anonymization Methods, Processes, and Challenges for Clinical Information Submissions to Health Canada
Cathal Gallagher
Associate Director Clinical Transparency & Trial Disclosure, Regeneron, United Kingdom
Do You Know Your Risk?
Lucy Mosquera, MSC
Senior Director, Data Science, Replica Analytics, Canada
Experiences Generating Synthetic Clinical Trial Data
Veera Thota
, MMS Holdings, United States
Automating Data Anonymization Procedures with Software
Pooja Phogat, PHD
Founder and Co-CEO, Krystelis Ltd., India
Actionable Insights for Plain Language Summary Implementation
Nirpal Virdee, MSC
Head, Transparency & Disclosure, Certara, United Kingdom
The Future of Transparency: How Global Regulatory Authorities May Expect Patient and HCP Engagement During the Drug Approval Process
Have an account?